Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
0.4500
+0.0010 (0.22%)
At close: Jul 18, 2025, 4:00 PM
0.4410
-0.0090 (-2.00%)
After-hours: Jul 18, 2025, 6:36 PM EDT
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $13.23 million as of July 18, 2025. Its market cap has decreased by -60.97% in one year.
Market Cap
13.23M
Enterprise Value
8.56M
1-Year Change
-60.97%
Ranking
Category
Stock Price
$0.45
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $13.23M, a decrease of -76.88%. That is a compound annual growth rate of -30.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2025 | 10.54M | -23.32% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 709.03B |
| Johnson & Johnson | 396.47B |
| AbbVie | 336.64B |
| Novo Nordisk | 301.36B |
| UnitedHealth Group | 265.33B |
| Novartis AG | 233.75B |
| Abbott Laboratories | 229.21B |
| AstraZeneca | 217.77B |